mdlinx mdlinx
Latest (427) Full Text Articles (11295) Article Summary

Clinical impact of intracoronary abciximab in patients undergoing primary percutaneous coronary intervention: an individual patient data pooled analysis of randomised studies
Heart,  Clinical Article

Piccolo R et al. – In ST–segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI), intracoronary abciximab administration, when compared with the intravenous standard route, can improve short–term clinical outcomes mainly by reducing the risk of death.

Methods
  • Individual data of 1198 patients enrolled in five trials were entered into the pooled analysis.
  • The primary endpoint of the study was the occurrence of all–cause death and reinfarction at 30–day follow–up.
  • Secondary endpoints were all–cause death, reinfarction and target–vessel revascularisation (TVR).

Results
  • No significant heterogeneity was found across trials.
  • Compared with the intravenous route, intracoronary abciximab administration significantly reduced the risk of the composite of death and reinfarction (HR 0.52, 95% CI 0.29 to 0.94; p=0.03), death (HR 0.44, 95% CI 0.20 to 0.95; p=0.04) and TVR (HR 0.53, 95% CI 0.29 to 0.99; p=0.045), without a significant impact on the risk of reinfarction (HR 0.54, 95% CI 0.24 to 1.21; p=0.13).
  • However, after correction for baseline differences, only the composite of death/reinfarction and death remained significant.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Medical Student

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Medical Student Articles

Last month's top read Top Articles of 2013

Indexed Journals in Medical Student: Academic Medicine, BMC Medical Education, Medical Teachermore

Other Topics in Medical Student

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close